EpiCapture

Dublin, Ireland Founded: 2021 • Age: 5 yrs Acquired By Trinity Biotech
Non-invasive liquid tests for cancer detection are developed.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About EpiCapture

EpiCapture is a company based in Dublin (Ireland) founded in 2021 was acquired by Trinity Biotech in October 2024. EpiCapture operates in a competitive market with competitors including Guardant Health, Natera, Denali Therapeutics, Foundation Medicine and ArcherDX, among others.

  • Headquarter Dublin, Ireland
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
  • Acquired by
    Trinity Biotech

    (Oct 25, 2024)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of EpiCapture

Premium access

Detailed funding history for EpiCapture

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in EpiCapture

EpiCapture has secured backing from 1 investor. Prominent investors backing the company include Trinity Biotech.

All
Investor Description Founded Year Domain Location
Provider of In vitro diagnostic kits for clinical labs
Locked Locked Locked
Premium access

Investor details for EpiCapture

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by EpiCapture

Investments
Premium access

Investment portfolio details for EpiCapture

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - EpiCapture

Premium access

Detailed financials for EpiCapture

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Epicapture Comparisons

EpiCapture Primary company
Description
Non-invasive liquid tests for cancer detection are developed...
Location
Dublin, Ireland
Founded Year
2021
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for EpiCapture

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of EpiCapture

EpiCapture operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Natera, Denali Therapeutics, Foundation Medicine and ArcherDX, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Digital sequencing technology for cancer detection is developed.
Locked Locked Locked
Developer of cell-free DNA testing for oncology, women’s health, and organ health
Locked Locked Locked
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
Locked Locked Locked
Genomics-based diagnostic tests for cancer are provided.
Locked Locked Locked
Molecular cancer diagnostic products are developed using patented AMP technology.
Locked Locked Locked
Health risks are identified through online genetic and diagnostic testing.
Premium access

Detailed competitors of EpiCapture

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Epicapture

Premium access

Complete news archive for EpiCapture

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about EpiCapture

EpiCapture was founded in 2021.

EpiCapture is headquartered in Dublin, Ireland.

EpiCapture was founded in 2021 in Dublin, Ireland, within the biotechnology sector. Non-invasive liquid biopsy tests for early cancer detection are developed by the company. These tests utilize epigenetic markers to identify cancer signals in bodily fluids, avoiding traditional invasive methods. Operations are based in Ireland, with a focus on advancing diagnostic tools for oncology applications. The domain epicapturedx.com supports ongoing research and development activities.

EpiCapture's top competitors include Guardant Health, Juno Therapeutics and Foundation Medicine.

EpiCapture has 1 investor. Key investors include Trinity Biotech.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available